Paragraph 2 Introductory Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below: Sch 5, para 5 am by Medicines for Human Use (Marketing Authorisations Etc.) 2003 reg 2 Sch.5, para.5(1)(f)(g) added by Medicines for Human Use (Marketing Authorisation Etc.) 1998 reg.3(1) Sch.5, para.5(2)(b) amended by Medicines for Human Use (Marketing Authorisation Etc.) 1998 reg.3(2) Sch. 5 para. 9 inserted by Medicines for Human Use 2009 reg. 2 Sch.5, para 5 amended by Medicines for Human Use (Marketing Authorisations Etc.) 2000 reg 5 Sch. 5 para. 2 words substituted by Medicines (Codification Amendments Etc.) 2002 reg. 8(i)(i) Sch. 5 para. 2 words substituted by Medicines (Codification Amendments Etc.) 2002 reg. 8(i)(ii) Sch 5, para 6 am by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2002 reg 3(1), (6) The requirements of this Schedule supplement those of Council Directive 92/27/EEC relating to: (a) special warnings necessary for particular medicinal products; (b) the legal status for supply to the patient, in accordance with Council Directive 92/26/EEC; (c) identification and authenticity. ← Paragraph 1 Paragraph 2 Paragraph 3 →